|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 33/00 | (2006.01) |
| A61M 16/22 | (2013.01) | ||
| A61P 25/22 | (2006.01) | ||
| A61M 16/06 | (2013.01) | ||
| A61K 33/36 | (2013.01) | ||
| A61M 21/02 | (2006.01) | ||
| A61F 9/029 | (2013.01) | ||
| A61K 31/137 | (2006.01) | ||
| A61M 16/00 | (2006.01) | ||
| A61M2202/0208 | (2013.01) | ||
| A61F 9/00 | (2006.01) | ||
| A61M 16/12 | (2013.01) | ||
| B82Y 5/00 | (2011.01) | ||
| A61M2210/0612 | (2013.01) | ||
| A61K 9/00 | (2006.01) | ||
| A61M2205/502 | (2013.01) | ||
| A61M 16/06 | (2006.01) | ||
| A61M2202/0291 | (2013.01) | ||
| A61M 16/12 | (2006.01) | ||
| B82Y 5/00 | (2013.01) | ||
| A61M 16/22 | (2006.01) | ||
| A61K 33/00 | (2013.01) | ||
| A61M 21/00 | (2006.01) | ||
| A61K 9/0048 | (2013.01) | ||
| A61F 9/02 | (2006.01) | ||
| A61M2202/0266 | (2013.01) | ||
| A61K 33/36 | (2006.01) | ||
| A61M 21/00 | (2013.01) | ||
| A61P 25/22 | (2018.01) | ||
| A61M 16/0891 | (2014.02) | ||
| A61M2250/00 | (2013.01) |
| (11) | Number of the document | 2931291 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13863444.9 |
| Date of filing the European patent application | 2013-12-10 | |
| (97) | Date of publication of the European application | 2015-10-21 |
| (45) | Date of publication and mention of the grant of the patent | 2021-10-20 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2013/074007 |
| Date | 2013-12-10 |
| (87) | Number | WO 2014/093277 |
| Date | 2014-06-19 |
| (30) | Number | Date | Country code |
| 201261735700 P | 2012-12-11 | US | |
| 201361815363 P | 2013-04-24 | US |
| (72) |
MELONI, Edward G. , US
KAUFMAN, Marc J. , US
|
| (73) |
The McLean Hospital Corporation ,
115 Mill Street, Belmont, MA 02487,
US
|
| (54) | XENON TREATMENT AS AN ADJUNCT TO PSYCHOTHERAPY FOR PSYCHIATRIC DISORDERS |
| XENON TREATMENT AS AN ADJUNCT TO PSYCHOTHERAPY FOR PSYCHIATRIC DISORDERS |